| 
             
			
			 In the survey of patients and physicians, doctors thought that 69 
			percent of patients were likely to die or need a transplant or 
			what’s know as a left ventricular assist device (LVAD) to help their 
			heart keep pumping within the next year. 
			 
			But just 14 percent of patients expected any of these outcomes to 
			happen to them, researchers report in JACC: Heart Failure. 
			 
			“Part of this is that hope is human nature - patients think they 
			will beat the odds,” said lead study author Dr. Amrut Ambardekar, 
			medical director of the cardiac transplant program at the University 
			of Colorado in Aurora. 
			 
			Almost 6 million Americans have heart failure, and it’s one of the 
			most common reasons older adults go to the hospital, according to 
			the American Heart Association. 
			
			  
			It happens when the heart muscle is too weak to pump enough blood 
			through the body. Symptoms can include fatigue, weight gain from 
			fluid retention, shortness of breath and coughing or wheezing. 
			Medications can help strengthen the heart and minimize fluid buildup 
			in the body. 
			 
			A realistic assessment of a patient's prospects is needed to make 
			decisions about interventions like heart transplantation or LVAD, 
			the study team writes. 
			 
			Unlike many other chronic health problems, the disease doesn’t 
			progress in a linear way, and that may contribute to the mismatch in 
			expectations between patients and doctors, Ambardekar said by email. 
			 
			“Patients have a hard time knowing their odds for survival as they 
			may have been at a low, but then responded to a treatment and 
			stabilized,” Ambardekar said. “Patients may have been sick, but then 
			responded to treatments in the past so they think they will respond 
			again.” 
			 
			For the study, physicians rated 161 patients on perceived risk for 
			transplant, LVAD or death in the upcoming year. The patients rated 
			themselves on the same risks. 
			 
			Predictions by both patients and physicians turned out to be poor, 
			the study team notes. 
			
            [to top of second column]  | 
            
             
  
            
			Overall, 21 percent of patients died during the study period. 
			Another 8 percent got transplants and 9 percent received LVAD 
			devices. 
			 
			Researchers also assessed whether patients were willing to consider 
			other life-sustaining therapies to treat advanced heart failure, 
			such as ventilation to help with breathing, dialysis to do the job 
			of failing kidneys or a feeding tube. 
			 
			While 77 percent of the patients considered high risk by physicians 
			said they would consider LVAD, 66 percent of them said they would 
			decline other life-sustaining therapies. 
			Beyond its small size, another limitation of the study is that 
			patients and doctors were surveyed only once, at the start of the 
			study, and it’s possible their perceptions of risk and willingness 
			to consider certain therapies or treatments might change over time, 
			the authors note. 
			 
			Even so, it suggests that there’s room for improvement in how 
			doctors and patients communicate, said Dr. Roberta Florido, a 
			researcher at Johns Hopkins University in Baltimore who wasn’t 
			involved in the study. 
			 
			“Whether altering one’s perception of their prognosis through 
			enhanced information makes them `healthier or happier longer’ is 
			unknown,” Florido said by email. “However, when patients are more 
			knowledgeable about their prognosis and care options, they are more 
			likely to make informed decisions about their goals and receive 
			medical care that is aligned with their preferences.” 
			 
			SOURCE: http://bit.ly/2wF5TuC JACC: Heart Failure, online August 16, 
			2017. 
			[© 2017 Thomson Reuters. All rights 
				reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			
			  
			
			
			   |